Aaron E. Royston, MD

Aaron Royston, MD is a Managing Partner at venBio with more than 15 years of experience in life sciences investing, company formation, and clinical research. He has been instrumental in launching and investing in numerous venBio companies, including Apellis Pharmaceuticals, Akero Therapeutics, Harmony Biosciences, Ventyx BioSciences, RayzeBio and ViceBio, whose efforts have collectively contributed to seven FDA approvals. Prior to joining venBio, Aaron was a member of the investment team at Vivo Capital and previously worked at Bain & Company, where he counseled biotechnology companies on strategic and operational issues. In 2010, he was recognized by the United States White House as a Champion of Change for his work in Technology and Innovation. He received a BS in Biological Sciences from Duke University and his MD and MBA from the University of Pennsylvania.